» Articles » PMID: 16462772

RORA, a Large Common Fragile Site Gene, is Involved in Cellular Stress Response

Overview
Journal Oncogene
Date 2006 Feb 8
PMID 16462772
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Common fragile sites (CFSs) are large genomic regions present in all individuals that are highly unstable and prone to breakage and rearrangement, especially in cancer cells with genomic instability. Eight of the 90 known CFSs have been precisely defined and five of these span genes that extend from 700 kb to over 1.5 Mb of genomic sequence. Although these genes reside within some of the most unstable chromosomal regions in the human genome, they are highly conserved evolutionarily. These genes are targets for large chromosomal deletions and rearrangements in cancer and are frequently inactivated in multiple tumor types. There is also an association between these genes and cellular responses to stress. Based upon the association between large genes and CFSs, we began to systematically test other large genes derived from chromosomal regions that were known to contain a CFS. In this study, we demonstrate that the 730 kb retinoic acid receptor-related orphan receptor alpha (RORA) gene is derived from the middle of the FRA15A (15q22.2) CFS. Although this gene is expressed in normal breast, prostate and ovarian epithelium, it is frequently inactivated in cancers that arise from these organs. RORA was previously shown to be involved in the cellular response to hypoxia and here we demonstrate changes in the amount of RORA message produced in cells exposed to a variety of different cellular stresses. Our results demonstrate that RORA is another very large CFS gene that is inactivated in multiple tumors. In addition, RORA appears to play a critical role in responses to cellular stress, lending further support to the idea that the large CFS genes function as part of a highly conserved stress response network that is uniquely susceptible to genomic instability in cancer cells.

Citing Articles

Identification of potential susceptibility loci for non-small cell lung cancer through whole genome sequencing in circadian rhythm genes.

Xu X, Xu L, Lang Z, Sun G, Pan J, Li X Sci Rep. 2025; 15(1):7825.

PMID: 40050692 PMC: 11885630. DOI: 10.1038/s41598-025-92083-9.


DNMT1-driven methylation of RORA facilitates esophageal squamous cell carcinoma progression under hypoxia through SLC2A3.

Yao W, Shang L, Wang Y, Xu L, Bai Y, Feng M J Transl Med. 2024; 22(1):1167.

PMID: 39741267 PMC: 11686977. DOI: 10.1186/s12967-024-05960-8.


Tumoral periprostatic adipose tissue exovesicles-derived miR-20a-5p regulates prostate cancer cell proliferation and inflammation through the RORA gene.

Sanchez-Martin S, Altuna-Coy A, Arreaza-Gil V, Bernal-Escote X, Fontgivell J, Ascaso-Til H J Transl Med. 2024; 22(1):661.

PMID: 39010137 PMC: 11251289. DOI: 10.1186/s12967-024-05458-3.


Regulation of RORα Stability through PRMT5-Dependent Symmetric Dimethylation.

Xiong G, Obringer B, Jones A, Horton E, Xu R Cancers (Basel). 2024; 16(10).

PMID: 38791992 PMC: 11120602. DOI: 10.3390/cancers16101914.


ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis.

De Vitis C, Battaglia A, Pallocca M, Santamaria G, Mimmi M, Sacco A J Exp Clin Cancer Res. 2023; 42(1):69.

PMID: 36945054 PMC: 10031988. DOI: 10.1186/s13046-023-02641-0.